{"id":"W7112191722","doi":"","title":"Temporary treatment cessation compared with continuation of tyrosine kinase inhibitors for adults with renal cancer: the STAR non-inferiority RCT","year":2024,"lang":"en","type":"article","venue":"White Rose Research Online (University of Leeds, The University of Sheffield, University of York)","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Programme Grants for Applied Research; Health Technology Assessment Programme; British Society of Interventional radiology; International Network of Agencies for Health Technology Assessment; Ipsen; European School of Oncology; Department of Health and Social Care; University of Leeds; National Institute for Health and Care Research; Bowel Cancer UK; British Heart Foundation; Engineering and Physical Sciences Research Council; AstraZeneca; National Cancer Research Institute; Cancer Research UK; Boston Scientific Corporation; GlaxoSmithKline; Amgen","keywords":"Randomized controlled trial; Confidence interval; Clinical trial; Continuation; Disease; Toxicity; Tyrosine-kinase inhibitor","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01279721,0.001193889,0.003647572,0.0005857381,0.000501739,0.002049757,0.0008309746,0.002518695,0.01440563],"category_scores_gemma":[0.02048142,0.0004976231,0.008199496,0.0007459479,0.001233722,0.002198556,0.001103978,0.004711106,0.001271366],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001263039,"about_ca_system_score_gemma":0.001776092,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001305385,"about_ca_topic_score_gemma":0.002280462,"domain_scores_codex":[0.9873023,0.009789381,0.00124399,0.0007380267,0.0004935334,0.0004327148],"domain_scores_gemma":[0.983328,0.01003874,0.003521155,0.001455486,0.0007907152,0.0008660025],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8922779,0.002147595,0.002211183,0.02063013,0.02560278,0.0000678879,0.0002566518,0.000432069,0.0006277811,0.001508388,0.003291255,0.05094646],"study_design_scores_gemma":[0.903017,0.04847505,0.006216325,0.004858262,0.02387208,0.0001014233,0.0002286018,0.0007520538,0.0003884412,0.003733178,0.00828959,0.00006811129],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.6789191,0.22531,0.01064228,0.01021822,0.007717498,0.03116583,0.00673493,0.0004820981,0.02881001],"genre_scores_gemma":[0.9473926,0.01896271,0.006394448,0.004781133,0.00208356,0.01462634,0.001462465,0.00007148184,0.00422519],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01440563,"threshold_uncertainty_score":0.06767893,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1718883935112557,"score_gpt":0.3554992116076738,"score_spread":0.1836108180964181,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}